New

Gastroparesis Market

2021

Gastroparesis Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Gastroparesis Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class Type (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)

Publication Month: Jan 2021 | Report Code: TIPRE00008992 | No. of Pages: 155 | Category: Pharmaceuticals | Status: Published

Market Insights

Gastroparesis Market to Grow at a CAGR of 4.3% to reach US$6,025.11 Million from 2020 to 2027

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The gastroparesis market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$6,025.11 millionby 2027; it is expected to grow at a CAGR of 4.3%from 2020 to 2027.

Gastroparesis is a medical condition characterized by the disability of stomach to empty itself of food in the usual way. Damaged nerves such as vagus nerves and muscles associated with gastric motility may also lead to gastroparesis. The condition is commonly observed in diabetic people. Gastroparesis can be classified as diabetic, idiopathic, and post-surgical on the basis of the cause. Apart from these, viral infections, nerve-related diseases, excessive narcotics and several antidepressant consumption, and amyloidosis may also lead to the onset of gastroparesis.

The COVID-19 pandemic has disrupted supply chain of over-the-counter (OTC) and prescription drugs, and this is likely to limit the market growth in the next few quarters. Moreover, the emphasis of health care providers and medical industries on COVID-19 has led to the lowered focus on the diagnosis and treatment for gastroparesis, which is limiting the market growth to a certain extent.

Lucrative Regions for Gastroparesis Market

Lucrative Regions for Gastroparesis Market

Get more information on this report :



Market Insights

Increasing Geriatric Population Accelerating Demand for Gastroparesis Treatment Modalities

Gastric emptying is associated with the coordination among the motor activity of proximal stomach, distal stomach, and duodenum. These internal organs are controlled by the feedback mechanism from neural signals generated through the interaction between nutrients and small intestine. Aging leads to diminished homeostatic regulations of physiologic functions, along with the slowing of gastric emptying. Moreover, it influences motor and sensory functions. In addition, geriatric population is highly vulnerable to gastroparesis due to factors such as the poor oral medication absorption, inadequate appetite regulation, and postprandial glycemia. According to the 2019 revision of World Population Prospects, 1 in 6 people would be aged more than 65 by 2050, with an increase from 1 in 11 in 2019. Furthermore, according to the same study, one in four people in Europe and North America is projected to be aged over 65 by 2050. Also, the number of people with age more than 80 would reach 426 million by 2050 from 143 million in 2019. Thus, the continuous increase in aging population, coupled with the rise in issues associated with gastric emptying among these populations, drives the gastroparesis market growth.

Type-Based Insights

On the basis of type, the gastroparesis market is segmented into idiopathic, diabetic, post-surgical, and others. The idiopathic segment held the largest share of the market in 2019, while the diabetic segment is estimated to register the highest CAGR during the forecast period.

Gastroparesis Market, by Type – 2019 and 2027

Gastroparesis Market, by Type – 2019 and 2027

Get more information on this report :


Drug Class Type-Based Insights

The gastroparesis market, based on drug class type, is segmented into prokinetic agents, antiemetic agents, and botulinum toxin injections. The prokinetic agents segment held the largest market share in 2019 and is estimated to register the highest CAGR during 2020–2027.

Distribution Channel-Based Insights

On the basis of distribution channel, the gastroparesis market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and the market for the same is estimated to grow at the highest CAGR from 2020 to 2027.

Strategic Insights

The gastroparesis market players have been adopting the strategy of product innovations to cater to dynamic customer demands, which also allows them to maintain their brand name in the global market.

Gastroparesis Market – by Type

  • Idiopathic
  • Diabetic
  • Post-surgical
  • Others

Gastroparesis Market – by Drug Class Type

  • Prokinetic Agents
  • Botulinum Toxin Injections
  • Antiemetic Agents

Gastroparesis Market – by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

GastroparesisMarket– by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South Americaand Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • EVOKE PHARMA
  • Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  • Johnson and Johnson Services, Inc.
  • Allergan Plc
  • NEUROGASTRX, INC.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Pfizer Inc.
  • ANI Pharmaceuticals, Inc.
  • Ipca Laboratories Ltd.
  • Cinrx Pharma, LLC (Cindome Pharma)

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Gastroparesis Market – By Type

1.3.2 Global Gastroparesis Market – By Drug Class Type

1.3.3 Global Gastroparesis Market – By Distribution Channel

1.3.4 Global Gastroparesis Market – By Geography

2. Gastroparesis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Gastroparesis Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America– PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific– PEST Analysis

4.2.4 Middle East & Africa- PEST Analysis

4.2.5 South and Central America- PEST Analysis

4.3 Expert Opinion

5. Gastroparesis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Diabetes Mellitus Prevalence

5.1.2 Increasing Geriatric Population

5.2 Market Restraints

5.2.1 Side Effects of Gastroparesis Drugs

5.3 Market Opportunities

5.3.1 Surging Investments and Financial Assistance for Research

5.4 Future Trends

5.4.1 Emphasis on Gastric Electrical Stimulation Therapy Research

5.5 Impact Analysis

6. Gastroparesis Market – Global Analysis

6.1 Global Gastroparesis Market Revenue Forecast And Analysis

6.2 Global Gastroparesis Market, By Geography - Forecast And Analysis

6.3 Market Positioning of Key Players

7. Gastroparesis Market Analysis – By Type

7.1 Overview

7.2 Gastroparesis Market Revenue Share, by Type (2019 and 2027)

7.3 Idiopathic

7.3.1 Overview

7.3.2 Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Diabetic

7.4.1 Overview

7.4.2 Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.5 Post-Surgical

7.5.1 Overview

7.5.2 Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8. Gastroparesis Market Analysis – By Drug Class Type

8.1 Overview

8.2 Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

8.3 Prokinetic Agents

8.3.1 Overview

8.3.2 Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Botulinum Toxin Injection

8.4.1 Overview

8.4.2 Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Antiemetic Agents

8.5.1 Overview

8.5.2 Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9. Gastroparesis Market Analysis – By Distribution Channel

9.1 Overview

9.2 Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3 Retail Pharmacies

9.3.1 Overview

9.3.2 Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Hospital Pharmacies

9.4.1 Overview

9.4.2 Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10. Gastroparesis Market – Geographic Analysis

10.1 North America: Gastroparesis Market

10.1.1 Overview

10.1.2 North America: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3 North America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4 North America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.5 North America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.6 North America: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.1.7 US: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1 US: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2 US Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3 US Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.4 US Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.8 Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1 Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2 Canada Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.3 Canada Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.4 Canada Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.9 Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1 Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2 Mexico Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3 Mexico Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.4 Mexico Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.2 Europe: Gastroparesis Market

10.2.1 Overview

10.2.2 Europe: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)

10.2.3 Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.4 Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.2.5 Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.2.6 Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.2.7 Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1 Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2 Germany Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.3 Germany Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.4 Germany Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.2.8 UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1 UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2 UK Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.3 UK Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.4 UK Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.2.9 France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1 France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2 France Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.3 France Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.4 France Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.2.10 Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Spain Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.3 Spain Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.4 Spain Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.2.11 Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1 Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2 Italy Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.3 Italy Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.4 Italy Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.2.12 Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.12.1 Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.2.12.2 Rest of Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.12.3 Rest of Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.2.12.4 Rest of Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.3 Asia Pacific: Gastroparesis Market

10.3.1 Overview

10.3.2 Asia Pacific: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)

10.3.3 Asia Pacific Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.4 Asia Pacific Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.3.4.1 Asia Pacific Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.5 Asia Pacific: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.3.6 China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.6.1 China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.6.2 China Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.6.3 China Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.3.6.3.1 China Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.7 Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.1 Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.2 Japan Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.7.3 Japan Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.3.7.3.1 Japan Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.8 India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1 India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.2 India Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.8.3 India Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.3.8.4 India Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.9 South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.1 South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.2 South Korea Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.9.3 South Korea Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.3.9.4 South Korea Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.10 Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1 Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 Australia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.10.3 Australia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.3.10.4 Australia Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.11 Rest of Asia Pacific: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1 Rest of Asia Pacific: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2 Rest of Asia Pacific Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.11.3 Rest of Asia Pacific Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.3.11.4 Rest of Asia Pacific Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.4 Middle East & Africa: Gastroparesis Market

10.4.1 Overview

10.4.2 Middle East & Africa: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)

10.4.3 Middle East & Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.4 Middle East & Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.4.5 Middle East & Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.4.6 Middle East & Africa: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.4.7 Saudi Arabia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.1 Saudi Arabia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.2 Saudi Arabia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.7.3 Saudi Arabia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.4.7.4 Saudi Arabia Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.4.8 UAE: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.1 UAE: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.2 UAE Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.3 UAE Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.4 UAE Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.4.9 South Africa: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.1 South Africa: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.2 South Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.9.3 South Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.4.9.4 South Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.4.9.5 Rest of Middle East and Africa: Gastroparesis Market - Revenue and Forecasts to 2027 (USD Million)

10.4.9.5.1 Rest of Middle East and Africa: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)

10.4.9.6 Rest of Middle East and Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.9.7 Rest of Middle East and Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.4.9.8 Rest of Middle East and Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.5 South and Central America: Gastroparesis Market

10.5.1 Overview

10.5.2 South and Central America: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.5.3 South and Central America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.4 South and Central America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.5.5 South and Central America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.5.6 South and Central America: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.5.7 Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1 Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.2 Brazil Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.3 Brazil Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.4 Brazil Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.5.8 Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.1 Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.2 Argentina Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.3 Argentina Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.4 Argentina Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.5.8.5 Rest of South and Central America: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)

10.5.8.5.1 Rest of South and Central America: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)

10.5.8.6 Rest of South and Central America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.7 Rest of South and Central America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.8 Rest of South and Central America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Gastroparesis Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment Of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Gastroparesis Market –Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Gastroparesis Market, 2018-2020

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Evoke Pharma

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Allergan Plc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 NEUROGASTRX, INC.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bausch Health Companies Inc.( Salix Pharmaceuticals)

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Johnson and Johnson Services, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Pfizer Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 ANI Pharmaceuticals, Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Ipca Laboratories Ltd

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 CinRx Pharma, LLC (CinDome Pharma)

13.10.1 Business Description

13.10.2 Products and Services

13.10.3 Financial Overview

13.10.4 SWOT Analysis

13.10.5 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Gastroparesis Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 2. North America Gastroparesis Market, by Drug Class Type– Revenue and Forecast to 2027 (USD Million)

Table 3. North America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 4. US Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5. US Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 6. US Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 7. Canada Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8. Canada Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 9. Canada Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 10. Mexico Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. Mexico Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 12. Mexico Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 13. Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14. Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 15. Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 16. Germany Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17. Germany Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 18. Germany Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 19. UK Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 20. UK Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 21. UK Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 22. France Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 23. France Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 24. France Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 25. Spain Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 26. Spain Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 27. Spain Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 28. Italy Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 29. Italy Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 30. Italy Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 31. Rest of Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 32. Rest of Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 33. Rest of Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 34. Asia Pacific Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 35. Asia Pacific Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 36. Asia Pacific Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 37. China Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 38. China Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 39. China Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 40. Japan Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 41. Japan Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 42. Japan Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 43. India Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 44. India Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 45. India Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 46. South Korea Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 47. South Korea Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 48. South Korea Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 49. Australia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 50. Australia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 51. Australia Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 52. Rest of Asia Pacific Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 53. Rest of Asia Pacific Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 54. Rest of Asia Pacific Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 55. Middle East & Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 56. Middle East & Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 57. Middle East & Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 58. Saudi Arabia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 59. Saudi Arabia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 60. Saudi Arabia Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 61. UAE Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 62. UAE Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 63. UAE Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 64. South Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 65. South Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 66. South Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 67. Rest of Middle East and Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 68. Rest of Middle East and Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 69. Rest of Middle East and Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 70. South and Central America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 71. South and Central America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 72. South and Central America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 73. Brazil Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 74. Brazil Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 75. Brazil Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 76. Argentina Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 77. Argentina Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 78. Argentina Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 79. Rest of South and Central America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 80. Rest of South and Central America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 81. Rest of South and Central America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 82. Recent Inorganic Growth Strategies in the Gastroparesis market

Table 83. Recent Organic Growth Strategies In the Gastroparesis market

Table 84. Glossary of Terms, Gastroparesis Market

LIST OF FIGURES

Figure 1. Gastroparesis Market Segmentation

Figure 2. Gastroparesis Market Segmentation, By Region

Figure 3. Gastroparesis Market Overview

Figure 4. Idiopathic Segment Held Largest Share of Gastroparesis Market

Figure 5. APAC to Show Remarkable Growth During Forecast Period

Figure 6. Gastroparesis Market, by Geography (US$ Million)

Figure 7. Global Gastroparesis Market – Leading Country Markets (US$ Million)

Figure 8. Global Gastroparesis Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East & Africa PEST Analysis

Figure 13. South and Central America PEST Analysis

Figure 14. Gastroparesis Market Impact Analysis of Drivers and Restraints

Figure 15. Global Gastroparesis Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16. Global Gastroparesis Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17. Market Positioning Of Key Players In Global Gastroparesis Market

Figure 18. Gastroparesis Market Revenue Share, by Type (2019 and 2027)

Figure 19. Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20. Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23. Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

Figure 24. Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25. Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26. Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27. Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 28. Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29. Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30. Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31. North America: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)

Figure 32. North America Gastroparesis Market Revenue and Forecast to 2027 (USD Million)

Figure 33. North America: Gastroparesis Market, by Country, 2019 & 2027 (%)

Figure 34. US: Pharmaceutical Drug Delivery market – Revenue and Forecast to 2027 (USD Million)

Figure 35. Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 36. Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 37. Europe: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)

Figure 38. Europe Gastroparesis Market Revenue and Forecast to 2027 (USD Million)

Figure 39. Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)

Figure 40. Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 41. UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 42. France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 43. Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 44. Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 45. Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 46. Asia Pacific: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)

Figure 47. Asia Pacific Gastroparesis Market Revenue and Forecast to 2027 (USD Million)

Figure 48. China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 49. Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 50. India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 51. South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 52. Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 53. Rest of Asia Pacific: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 54. Middle East & Africa: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)

Figure 55. Middle East & Africa Gastroparesis Market Revenue and Forecast to 2027 (USD Million)

Figure 56. Middle East & Africa: Gastroparesis Market, by Country, 2019 & 2027 (%)

Figure 57. Saudi Arabia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 58. UAE: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 59. South Africa: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 60. Rest of Middle East and Africa: Gastroparesis Market- Revenue And Forecasts To 2027 (USD Million)

Figure 61. South and Central America: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)

Figure 62. South and Central America Gastroparesis Market Revenue and Forecast to 2027 (USD Million)

Figure 63. South and Central America: Gastroparesis Market, by Country, 2019 & 2027 (%)

Figure 64. Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 65. Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 66. Rest of South and Central America: Gastroparesis Market- Revenue And Forecasts To 2027 (USD Million)

Figure 67. Impact of COVID-19 Pandemic in North American Country Markets

Figure 68. Impact of COVID-19 Pandemic in European Country Markets

Figure 69. Impact of COVID-19 Pandemic on Gastroparesis Market in Asia Pacific Countries

Figure 70. Impact Of COVID-19 Pandemic in Middle East and Africa Market

Figure 71. Impact Of COVID-19 Pandemic in South and Central America Market

Figure 72. Growth Strategies in the Gastroparesis Market, 2018-2020

The List of Companies - Gastroparesis Market

  1. EVOKE PHARMA
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Johnson and Johnson Services, Inc.
  4. Allergan Plc
  5. NEUROGASTRX, INC.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD
  7. Pfizer Inc.
  8. ANI Pharmaceuticals, Inc.
  9. Ipca Laboratories Ltd.
  10. Cinrx Pharma, LLC (Cindome Pharma)  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the gastroparesis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global gastroparesis market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00008992
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Gastroparesis is a condition where the stomach cannot empty itself of food in the usual way. Moreover, the damaged nerves such as vagus nerves and muscles associated with gastric motility may also lead to gastroparesis. The condition is substantially observed in the diabetic population. Gastroparesis can be classified as diabetic, idiopathic, and post-surgical on the basis of causes. Apart from these viral infections, nerve-related diseases, excessive consumption of narcotics and some antidepressants, and amyloidosis may also lead to the occurrence of gastroparesis.

The growth of the market is attributed to some key driving factors such as increasing prevalence of diabetes and growing geriatric population.

The gastroparesis market majorly consists of the players such as EVOKE PHARMA, Bausch Health Companies Inc.(Salix Pharmaceuticals, Ltd.), Johnson And Johnson Services, Inc., Allergan Plc, NEUROGASTRX, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD, Pfizer Inc., ANI Pharmaceuticals, Inc., Ipca Laboratories Ltd., And Cinrx Pharma, LLC (Cindome Pharma) amongst others.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.